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RESEARCH ARTICLE
Insoluble Aβ overexpression in an App knock-in mouse model
alters microstructure and gamma oscillations in the prefrontal
cortex, affecting anxiety-related behaviours
Eleftheria Pervolaraki1, Stephen P. Hall2, Denise Foresteire3, Takashi Saito4, Takaomi C. Saido4,
Miles A. Whittington2, Colin Lever3 and James Dachtler3,*
ABSTRACT
We studied a new amyloid-beta precursor protein (App) knock-in
mouse model of Alzheimer’s disease (AppNL-G-F), containing the
Swedish KM670/671NL mutation, the Iberian I716F mutation and the
Artic E693G mutation, which generates elevated levels of amyloid
beta (Aβ)40 and Aβ42 without the confounds associated with APP
overexpression. This enabled us to assess changes in anxiety-related
and social behaviours, and neural alterations potentially underlying
such changes, driven specifically by Aβ accumulation. AppNL-G-F
knock-in mice exhibited subtle deficits in tasks assessing social
olfaction, but not in social motivation tasks. In anxiety-assessing tasks,
AppNL-G-F knock-in mice exhibited: (1) increased thigmotaxis in the
open field (OF), yet; (2) reduced closed-arm, and increased open-arm,
time in the elevated plus maze (EPM). Their ostensibly anxiogenic OF
profile, yet ostensibly anxiolytic EPM profile, could hint at altered
cortical mechanisms affecting decision-making (e.g. ‘disinhibition’),
rather than simple core deficits in emotional motivation. Consistent with
this possibility, alterations in microstructure, glutamatergic-dependent
gamma oscillations and glutamatergic gene expression were all
observed in the prefrontal cortex, but not the amygdala, of AppNL-G-F
knock-in mice. Thus, insoluble Aβ overexpression drives prefrontal
cortical alterations, potentially underlying changes in social and
anxiety-related behavioural tasks.
This article has an associated First Person interview with the first
author of the paper.
KEY WORDS: Alzheimer’s disease, AppNL-G-F knock-in mice,
Anxiety, Prefrontal cortex, Gamma oscillations, Social
INTRODUCTION
Alzheimer’s disease (AD) is classically associated with declining
cognitive function (Scheltens et al., 2016). However, this is only one
aspect of the behavioural changes associated with AD. Other
behavioural changes include reduced social engagement and
increased anxiety. Although social aspects of AD have remained
underexplored, social withdrawal is present up to 5 years prior to a
clinical cognitive diagnosis (Jost and Grossberg, 1995). AD patients
with larger social networks (the number of peoplewith which one has
meaningful contact with) have slower cognitive decline, compared to
AD patients with small social networks (Bennett et al., 2006). Social
factors may modulate the rate of disease pathology and cognitive
decline but, crucially, also the chance of developing AD (Kuiper
et al., 2015). Studies have found that, for elderly people who identify
as lonely, the risk of developing AD was nearly doubled (Wilson
et al., 2007). Recent evidence from the Lancet Commission Report
highlights that social isolation constitutes 2.3%of the total risk factors
for developing AD (Livingston et al., 2017). Thus, social factors not
only modulate the risk of developing dementia, but also disease
progression. Together, it can be inferred that changes in social
motivation of the individual, as a result of AD pathology, may be a
factor in disease progression.
Anxiety in AD is relatively common, with up to 71% of patients
reporting anxiety concerns (Ferretti et al., 2001; Teri et al., 1999).
Up to 6% had anxiety that reached the diagnostic criteria of
generalised anxiety disorder of the Diagnostic and Statistical
Manual of Mental Disorders (Ferretti et al., 2001). Anxiety
behaviours may also predict conversion to AD. Mild cognitive
impairment (MCI) is often the precursor condition to AD. In total,
83.3% of MCI patients that also exhibited anxiety symptoms
converted to AD within a 3-year follow-up period compared to
40.9% of persons with MCI but without anxiety (Palmer et al.,
2007). This and other studies (Gallagher et al., 2011; Li and Li,
2018; Pietrzak et al., 2015) suggest that anxiety is associated with
early phases of AD. Neurodegeneration in early ADmay explain the
increase in anxiety. The presence of anxiety is associated with
abnormal cerebrospinal fluid (CSF) Aβ42 and tau in MCI patients
(Ramakers et al., 2013), and thus may reflect underlying pathology.
In summary, social-related and anxiety-related changes in AD can
occur early in, and predict, disease progression.
The AD-affected neural regions relevant to changes in anxiety
and social behaviours remain unclear, but candidate regions of
interest (ROIs) for the present study were the hippocampus,
amygdala and prefrontal cortex. Our rationale for these ROIs was
twofold. First, these regions have been consistently linked to anxiety
and social behaviours (e.g. hippocampus: Bannerman et al., 2004;
Hitti and Siegelbaum, 2014; Okuyama et al., 2016; amygdala: Shin
and Liberzon, 2010; prefrontal cortex: Cao et al., 2018). Second,
pathology in these regions can occur early in AD and predict MCI-
to-AD conversion (e.g. hippocampus: Devanand et al., 2007; Liu
et al., 2010; amygdala: Liu et al., 2010; Poulin et al., 2011;
prefrontal cortex: Okello et al., 2009; Plant et al., 2010; Tondelli
et al., 2012). Interestingly, in Okello et al. (2009), the anteriorReceived 16 May 2019; Accepted 15 August 2019
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cingulate cortex (ACC) had the highest amyloid-beta (Aβ) load of
six ROIs in MCI patients relative to controls, and a higher anterior
cingulate Aβ load predicted faster conversion from MCI to AD.
Currently, we have few insights into the biological mechanisms
underpinning anxiety and social withdrawal in AD, highlighting the
need to find AD mice that model these behaviours.
A biological mechanism that has been associated with dysfunction
in AD are gamma oscillations. Gamma disruption has been
demonstrated in other AD mouse models, such as the APP/PS1
model (Klein et al., 2016), the TAS10 overexpression model (Driver
et al., 2007) and in the entorhinal cortex of AppNL-G-F knock-in (KI)
mice (Nakazono et al., 2017), and these impairments occur relatively
early in Aβ-driven pathological processes. Gamma oscillations have
been widely associated with roles in learning and memory (Tallon-
Baudry et al., 1998), and attention (Fries et al., 2001), whilst
coherence between brain regions has been demonstrated to facilitate
information transfer (Buzsaki and Wang, 2012). Specifically in the
prefrontal cortex, gamma oscillations have been shown to be
important for social behaviour (Cao et al., 2018) and anxiety
behaviours (Dzirasa et al., 2011; Stujenske et al., 2014). Thus,
gamma oscillations represent a useful target for exploring network-
level sequelae of AD-related pathology, relevant to social and
anxiety-related behaviour. N-methyl-D-aspartate (NMDA) receptors
(heteromeric complexes formed from GluN1 and GluN2A-GluN2D)
are necessary for excitatory glutamatergic neurotransmission. NMDA
dysfunction is well established in AD, such that one of the few drugs
to ameliorate the symptoms of AD is the NMDA antagonist
memantine (Lipton, 2006). Post-mortem studies have indicated that
GluN1/GluN2B heterodimer expression significantly decreases with
increasing AD pathology, whereas GluN1/GluN2A receptors
(another form of the fast NMDA receptor) remain unchanged
(Mishizen-Eberz et al., 2004). Thus, the contribution of NMDA
receptors to normal synaptic function in AD is worth exploring.
Broadly speaking, the majority of work to examine the pathologies
underpinning AD have tended to focus upon amylogenic pathways.
The majority of these model the amyloid aspects of AD through Aβ
plaques. Despite many transgenic mouse models of AD existing,
previous generations of Aβ mice have achieved their Aβ
overexpression by also overexpressing amyloid precursor protein
(APP). Over time, it has become clear that APP overexpression alone
can introduce confounds that make it difficult to dissociate the causal
effects of Aβ compared to APP. Mice overexpressing human wild-
type APP have cognitive impairments in the Morris water maze and
object-recognition test, increased tau hyperphosphorylation and
reduced GluA1, GluA2, GluN1, GluN2A, GluN2B, phosphorylated
CaMKII and PSD95 (Simón et al., 2009). This was also associated
with reduced cell density in the pyramidal layer of CA1 (Simón et al.,
2009). Others have found that other Aβmice (APP23 mice) produced
higher amounts of APP fragments, including C-terminal fragment β/α
and APP intracellular domain (Saito et al., 2014). The phenotypes
associated with APP overexpression alone encapsulate what are
known to be AD-specific pathologies, underlining the potential risks
of using APP overexpression models to make AD interpretations.
Recently, a new generation of AD mouse models have become
available that achieve Aβ pathologies without the overexpression of
APP (Saito et al., 2014). This has been achieved by humanising the
murine Aβ sequence through a KI strategy. Up to three familial
mutations have been knocked-in to generate two AD mouse models.
The AppNL-G-F mouse contains the Swedish KM670/671NL mutation
and the Iberian I716F mutation, which results in elevated total Aβ and
elevated Aβ42/Aβ40 ratio, and the additional Artic mutation E693G,
which promotes aggressive Aβ oligomerisation and amyloidosis (Saito
et al., 2014). In AppNL-G-Fmice, Aβ plaques are saturated by 9 months
of age. Hence, AppNL-G-F mice are useful to understand the effects of
plaque-based Aβ in the generation of AD-related pathologies.
Within the current study, we have sought to explore whether these
new AppKI mouse models display alterations in behaviours related to
social motivation, social memory and anxiety. Briefly, in terms of
behaviour, we found marked, yet seemingly contradictory, changes in
anxiety tasks [‘anxiogenic’ in the open field (OF), ‘anxiolytic’ in the
elevated plusmaze (EPM)], together withmild deficits on social tasks,
in AppNL-G-F KI mice. Arguably, the marked anxiety-related
behavioural changes pointed more towards changes in decision-
making than towards a simple shift in core anxiety-related
emotionality. Accordingly, we applied three methodological assays
to these mice, probing aspects of anatomy, physiology and genetics,
with each assay consistently targeting both the prefrontal cortex
(which has long been linked to decision-making interfacing affect and
cognition) and the basolateral amygdala (which has long been linked
to anxiety-related emotionality). Consistent with decision-making
being affected more than core emotionality (albeit with other possible
interpretations), we found that the prefrontal cortex exhibited
alterations in all three of our assays (microstructure, glutamatergic-
dependent gamma oscillations and glutamatergic gene expression),
while the basolateral amygdala exhibited alterations in none of them.
We conclude that insoluble Aβ overexpression leads to alterations in
prefrontal cortices (as well as the hippocampus), which could at least
partially underlie changes in social and anxiety-related tasks.
RESULTS
AppNL-G-F KI mice show changes in anxiety-assessing tasks
To assess the potential role of Aβ in anxiety, we undertook two
behavioural paradigms that are widely used to probe anxiety in
rodents: the OF test and the EPM. In the OF, mice were allowed to
freely ambulate for 30 mins, during which we measured the distance
they travelled in 5 min blocks. We observed that AppNL-G-F KI mice
travelled a similar distance to wild-type mice (Fig. 1A; genotype
F(1,35)=1.93, P=0.174, time block × genotype × sex F(1,55) <1,
P=0.703, genotype × sex F(1,35)=2.09, P=0.157), suggesting that
AppNL-G-F KI mice do not have any overt deficiencies in motor
function. We subsequently divided the floor of the arena into an outer
zone, an intermediate zone and a centre zone (see Materials and
Methods) to determine whether AppNL-G-F KI mice displayed a
propensity to stay close to the walls (thigmotaxis) and avoid the centre.
Notably, AppNL-G-F KI mice spend markedly more time in the outer
zone (i.e. against the walls) (Fig. 1B; genotype F(1,35)=24.47,
P<0.0001, genotype × sex F(1,35)<1, P=0.994). Further suggesting
an anxiogenic phenotype, AppNL-G-F KI mice spent significantly less
time in the centre zone (Fig. 1C; genotype F(1,35)=18.36, P<0.0001,
genotype × sex F(1,35)<1, P=0.832). Although no differences between
the genotypeswere observed for entries to the outer zone,AppNL-G-FKI
mice made fewer entries to the centre zone (Fig. S1A,B, see figure
legend for statistics). Based on both outer zone entries and total
distance travelled (see above), it is unlikely that hypo- or hyperactivity
inAppNL-G-FKImice can explain the observed behavioural differences.
We next examined whether AppNL-G-F KI mice also had a similarly
anxiogenic profile in the EPM. Surprisingly, AppNL-G-FKI mice spent
significantly more time in the EPM’s open arms (Fig. 1D; genotype
F(1,35)=6.51, P=0.015, genotype × sex F(1,35)<1, P=0.578) and
markedly less time in the EPM’s closed arms (Fig. 1E; genotype
F(1,35)=9.05, P=0.005, genotype × sex F(1,35)<1, P=0.651).
Furthermore, AppNL-G-F KI mice spent markedly less time in the
centre zone (see Fig. S1C for statistics), and made significantly more
head dips (see Fig. S1D for statistics). As with the OF, the specificity
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of the differences is unlikely to be explained by hyper- or hypoactivity,
as AppNL-G-F KI mice travelled a similar distance within the test (see
Fig. S1E for statistics). In summary, AppNL-G-F KI mice show
anxiety-related behaviours that differ between experimental
paradigms; anxiogenic in the OF, anxiolytic in the EPM.
To explore whether social motivation was altered in App KI mice,
we examined sociability in the three-chambered social approach test
(Moy et al., 2004; Nadler et al., 2004), which exploits the preference
of a mouse to explore a novel mouse enclosed within a wire cage
compared to an identical empty cage. All genotypes showed a clear,
similar preference for exploring the cage containing the novel mouse
(Fig. 2A: genotype F(1,35)<1, P=0.670, discrimination between the
novel mouse and empty cage F(1,35)=123.88, P<0.0001, genotype ×
discrimination between the novel mouse and empty cage
F(1,35)=1.33, P=0.257, genotype × sex F(1,35)=1.36, P=0.252).
Next, we tested whether App KI mice were able to show social
novelty recognition by preferentially exploring a second novel
conspecific over a previously explored conspecific (Fig. 2B). We
found that discrimination was, albeit not significantly, weaker in
AppNL-G-F KI mice (F(1,35)=3.42, P=0.073). There were no significant
differences between genotype and sex (F(2,35)<1, P=0.955), nor was
there any difference in genotypic discrimination of the novel and
familiar mouse by sex (genotype × discrimination between the novel
mouse and familiar mouse × sexF(1,35)<1,P=0.681). Thus, only subtle
deficits exist for social recognition memory in AppNL-G-F KI mice.
Finally, we tested whether App KI mice showed motivation to
explore a social smell (soiled bedding) compared to a non-social
smell (clean bedding). Discrimination between the social and
non-social olfactory stimulus differed by sex and genotype
(genotype × discrimination × sex F(1,35)=12.50, P=0.001,
genotype × discrimination F(1, 35)=4.30, P=0.045). To investigate
the source of difference, we performed further statistical analysis on
whether social olfaction performance of AppNL-G-FKI mice differed
by sex. For males (Fig. 2C), both genotypes showed discrimination
for the social olfactory cue (simple effects analysis, F(1,35)<1).
However, female AppNL-G-F KI mice displayed significantly weaker
discrimination between the social and non-social olfactory stimulus
compared to female wild-type mice (Fig. 2D; simple effects
analysis, F(1,35)=10.55, P=0.003).
AppNL-G-F KI mice have microstructural changes in the
prefrontal cortex and hippocampus
Given the behavioural changes in theOF,EPMand social olfaction test,
we decided to explore putative neurobiological mechanisms that may
explain these impairments. Our approach was to examine the integrity
of brain regions associated with both social and anxiety behaviours
(see Materials and Methods). These centred upon the prefrontal cortex
[orbitofrontal cortex (OFC) and ACC], the hippocampus (anterior and
posterior) and the amygdala [including the basolateral amygdala
(BLA)]. To derive quantitative measures of diffusion tensor imaging
(DTI), we examined fractional anisotropy (FA) and mean diffusivity
(MD), examiningdiffusion across the λ1,λ2 andλ3 vectors, followed by
axial diffusivity (AxD) and radial diffusivity (RD) to determine
preferential diffusion along the λ1, or λ2 and λ3 vectors, respectively.
Fig. 1. Anxiety behaviours in
8-month-old AppNL-G-F KI mice in the
open field (OF) and elevated plus
maze (EPM). (A) Given 30 min free
ambulation, all genotypes expressed
similar amounts of locomotor activity as
quantified by distance travelled.
(B,C) AppNL-G-F KI mice displayed
thigmotaxis in the OF, spending
significantly more time against thewalls
(B) and less time in the centre zone (C).
(D,E) Conversely, AppNL-G-F KI mice
spent significantly more time exploring
the open arms of the EPM (D) and
significantly less time within the closed
arms (E), suggesting an anxiolytic
profile. All statistics used two-way
ANOVAs. ***P<0.001, **P<0.01,
*P<0.05. Error bars are s.e.m. Wild-
type n=21, AppNL-G-F KI n=19.
3
RESEARCH ARTICLE Disease Models & Mechanisms (2019) 12, dmm040550. doi:10.1242/dmm.040550
D
is
ea
se
M
o
d
el
s
&
M
ec
h
an
is
m
s
Given that the amygdala has been widely associated with both
social and anxiety behaviours (Adolphs, 2010; Davis, 1992; Davis
et al., 1994), we segmented the whole amygdala region, in anterior
and posterior planes, and, separately, the BLA, to determine
whether structural alterations may explain the behavioural changes.
For all measures (FA, MD, AxD and RD), in both the anterior and
posterior amygdala, plus the BLA, we did not observe any
significant changes in tissue diffusion properties (Table S1 for
non-significant statistics and Fig. S2).
Ventral hippocampal regions of the posterior hippocampus are
associated with unconditioned anxiety as tested by OF and EPM tasks
(Bannerman et al., 2004), whilst dorsal and ventral regions are
increasingly being associated with social recognition across the whole
hippocampal extent (Hitti and Siegelbaum, 2014; Okuyama et al.,
2016). We therefore next examined the microstructure of the
hippocampus along the anterior to posterior axis. FA of the anterior
(Fig. 3A) and posterior (Fig. 3B) hippocampus did not differ between
wild-type and AppNL-G-F KI mice (Table S2 for non-significant
statistics). However, whilst MD in the anterior hippocampus (Fig. 3C)
was similar between the genotypes (F(1,14)<1, P=0.263), MD was
significantly higher in the posterior hippocampus (Fig. 3D) ofAppNL-G-F
KI mice (F(1,14)=12.18, P=0.011). For AxD, App
NL-G-FKI mice had
significantly increased diffusion in the anterior hippocampus (Fig. 3E;
F(1,14)=7.55, P=0.047) but not in the posterior hippocampus (Fig. 3F;
F(1,14)=4.45, P=0.068). RD was significantly higher in App
NL-G-F KI
mice in the posterior hippocampus (Fig. 3G; F(1,14)=18.13, P=0.005)
but not the anterior hippocampus (Fig. 3H; F(1,14)=1.52, P=0.142). In
summary, diffusion changes in the hippocampus were not marked,
with significant changes only in anterior hippocampal AxD and
posterior hippocampal RD.
We next segmented two prefrontal cortical regions: theOFC and the
ACC. In addition to roles for OFC and ACC regions in anxiety and
social behaviours, resting-state functionalmagnetic resonance imaging
(rsfMRI) has shown that connectivity of themedial prefrontal cortex to
other regions is abnormal in AppNL-G-F KI mice, with the ACC being
the most altered region (Latif-Hernandez et al., 2017). However, it is
currently unknown as to whether structural changes in the ACC
contributed to the rsfMRI result. In the OFC of AppNL-G-F KI mice,
there were no significant differences in FA (Fig. 4A; genotype
F(1,14)=4.51, P=0.063); however, MD was significantly increased
(Fig. 4B; genotype F(1,14)=8.61, P=0.026). Similarly, for the ACC,
FA was similar between the genotypes (Fig. 4C; genotype t(14) <1,
P=0.37) but MD was significantly increased (Fig. 4D; genotype
t(14)=3.13, P=0.021). We further explored prefrontal cortical changes
by quantifying AxD and RD. In the OFC, both AxD and RD were
significantly increased in AppNL-G-F KI mice [F(1,14)=8.34, P=0.032
(Fig. 4E) and F(1,14)=8.23, P=0.042 (Fig. 4F), respectively]. AxD and
RDwere also significantly increased in the ACCofAppNL-G-FKImice
[t(14)=2.88, P=0.037 (Fig. 4G) and t(14)=3.19, P=0.016 (Fig. 4H)]. In
summary, for both theOFCandACC, FAwas not significantly altered,
but MD, AxD and RD were all increased in AppNL-G-F KI mice.
Significant increases in three of these DTI measures likely reflects
widespread pathology in theOFC andACCofAppNL-G-FKImice. The
DTI-related alterations in these prefrontal regions notably contrasted
with an absence of any alterations in DTI measures in the amygdala.
Finally, we performed amyloid plaque staining on the
corresponding tissue sections that were analysed for DTI. By
9 months of age in AppNL-G-F KI mice, the OFC, ACC, amygdala
and hippocampus all exhibit substantial plaque load (Fig. S3),
indicating that the lack of DTI changes in the amygdala are not due to
an absence of amyloid plaques.
Alterations in prefrontal cortical NMDA-dependent gamma
oscillations in AppNL-G-F KI mice
Although some microstructural changes were detected in the
hippocampus of AppNL-G-F KI mice (anterior hippocampal AxD
Fig. 2. Social behaviours in AppNL-G-F KI
mice. (A) All genotypes showed a similar
preference for exploring a novel, same-sexed
novel conspecific (Stranger 1), compared to an
empty cage. (B) However, AppNL-G-F KI mice
displayed a marginally weaker discrimination
between the previously explored mouse
(Stranger 1) and a second novel conspecific
(Stranger 2). (C,D) Mice were then required to
discriminate between a social smell (soiled
bedding) or a non-social smell (clean
bedding). Although all male genotypes show a
similar preference for exploring the social cue
compared to male wild-type mice (C), female
AppNL-G-F KI mice show significantly weaker
discrimination compared to female wild-type
mice (D). All statistics used two-way ANOVAs.
**P<0.01. Error bars are s.e.m. Wild-type:
male n=9, female n=11; AppNL-G-F KI: male
n=10, female n=9.
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and posterior hippocampal RD), these were relatively inconsistent
compared to the alterations observed within the prefrontal cortex.
Another study found the ACC as being the most significantly altered
brain region in AppNL-G-F KI mice as detected by rsfMRI (Latif-
Hernandez et al., 2017). This suggests that substantial changes are
occurring in the ACC in AppNL-G-F KI mice, as broadly consistent
with the ACC Aβ load being high in MCI, and predicting faster
conversion to AD (Okello et al., 2009). As such, and given the
importance of the ACC and amygdala to anxiety and social
behaviours, we decided to contrast these two regions to examine
whether altered network physiology might accompany DTI-derived
microstructural alterations.
We generated gamma oscillations in brain slices using
kainate and tested their dependency on NMDA receptors,
which have previously been shown to modulate peak frequency
through inhibitory postsynaptic currents (Carlén et al., 2012;
McNally et al., 2011), by modifying recruitment of different
interneuron subpopulations (Middleton et al., 2008). Gamma
oscillations in non-pharmacologically treated slices were
generally, in terms of peak amplitude and frequency, very
similar between wild-type and AppNL-G-F KI mice in both the
BLA and the ACC. Within the BLA of the amygdala, we found
that, in wild-type mice, peak amplitude and frequency of
gamma oscillations were unaffected by the application of the
Fig. 3. Alterations in fractional anisotropy (FA)
and mean diffusivity (MD) in the hippocampus.
Diffusion tensor imaging (DTI) images of the
hippocampus were segmented at two regions:
anterior (bregma −1.94 mm) and posterior (bregma
−3.28 mm). FA was not significantly altered
between the wild-type and AppNL-G-F KI mice in the
anterior (A) and posterior (B) hippocampus. MD of
the anterior hippocampus did not differ between the
genotypes (C); however, MD in the posterior
hippocampus was significantly higher in AppNL-G-F
KI mice (D). Diffusivity was further characterised by
examining axial (AxD) and radial (RD) diffusivity.
AxD was significantly increased in the anterior
hippocampus of AppNL-G-F KI mice (E), but not in
the posterior hippocampus (F). RD did not differ
between the genotypes in the anterior
hippocampus, but AppNL-G-F KI mice had
significantly increased RD in the posterior
hippocampus compared to wild-type mice. All
statistics used two-way ANOVAs. **P<0.01,
*P<0.05. Error bars are s.e.m. Wild-type n=8,
AppNL-G-F KI n=8.
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broad-spectrum NMDA receptor antagonist CPP (Fig. 5Aiii;
t(14)<1, P=0.991 and t(14)<1, P=0.656, respectively). We
observed similar results in the AppNL-G-F KI mice, with peak
amplitude and frequency unaffected by NMDA antagonism
(Fig. 5Aiv; t(14)<1, P=0.951 and t(14)<1, P=0.709,
respectively). Together, this suggests that gamma oscillations
in the BLA in AppNL-G-F KI mice are unaffected by Aβ
deposition.
Next, we studied gamma oscillations within the ACC of the
prefrontal cortex. In wild-type mice, the frequency of gamma
oscillations was unaffected by CPP (Fig. 5Biii; t(14)=1.91,
P=0.086). However, gamma peak amplitude was significantly
reduced by CPP application (Fig. 5Biv; t(14)=2.96, P=0.014),
suggesting that, as expected (e.g. Carlén et al., 2012), ACC gamma
oscillations normally require NMDA receptors in wild-type
conditions. In contrast, in AppNL-G-F KI mice, gamma amplitude
(and frequency) were unaltered by NMDA receptor antagonism
(t(14)<1, P=0.404; t(14)<1, P=0.430, respectively), suggesting that
ACC gamma oscillations in AppNL-G-F KI mice have lost their
dependency upon NMDA receptors. In summary, the contribution
of NMDA receptors to gamma oscillatory mechanisms appeared
abnormally reduced in the prefrontal cortex.
Fig. 4. Alterations in fractional anisotropy (FA)
and mean diffusivity (MD) in the orbitofrontal
cortex and anterior cingulate cortex (ACC) of
the prefrontal cortex. Diffusion tensor imaging
(DTI) images were segmented for the orbitofrontal
cortex at bregma +2.58 mm and for the ACC at
bregma +1.18 mm. FAwas not significantly altered
between wild-type and AppNL-G-F KI mice in the
orbitofrontal cortex (A); however, MD was
significantly higher for AppNL-G-F KI mice (B).
Similarly, FA did not differ between the genotypes
for the ACC (C), but MD was significantly higher in
AppNL-G-F KI mice (D). Axial (AxD) and radial (RD)
diffusivity was then analysed. In AppNL-G-F KI mice,
AxD (E) and RD (F) were both significantly
increased in the orbitofrontal cortex. AxD (G) and
RD (H) were also both increased in AppNL-G-F KI
mice in the ACC. A, B, E and F used two-way
ANOVAs. C, D, G and H used t-tests. *P<0.05.
Error bars are s.e.m. Wild-type n=8, AppNL-G-F KI
n=8.
6
RESEARCH ARTICLE Disease Models & Mechanisms (2019) 12, dmm040550. doi:10.1242/dmm.040550
D
is
ea
se
M
o
d
el
s
&
M
ec
h
an
is
m
s
Prefrontal NMDA receptor expression is reduced in AppNL-G-F
KI mice
To further understand this pattern of NMDA-receptor-related
alterations in gamma oscillations in the prefrontal cortex but not
the BLA, we next analysed the mRNA expression of synaptic genes,
including NMDA receptors and pre- and postsynaptic receptors
relating to NMDA receptor function. Within the amygdala,
although we generally observed higher gene expression in AppNL-
G-F KI mice (Fig. 6A), no significant genotypic differences were
observed for Dlg4 (t(10)=2.14, P=0.058), Grin1 (t(10)=1.97,
P=0.078), Grin2a (t(10)=2.16, P=0.056), Grin2b (t(10)<1, P=0.455)
or Stxbp1 (t(10)=1.27, P=0.234). We next examined the mRNA
expression in the frontal cortex (Fig. 6B). We did not observe any
significant differences between wild-type and AppNL-G-F KI mice for
the genes Dlg4 (t(10)<1, P=0.420), Grin1 (t(10)<1, P=0.780) and
Grin2a (t(10)<1, P=0.731). However, the expression of Grin2b
(t(10)=2.59, P=0.027), which encodes the 2B subunit of the NMDA
receptor, and Stxbp1 (t(10)=2.66,P=0.024), which encodesMunc18-1,
was significantly reduced in AppNL-G-F KI mice. Together, the
change in the dependency of NMDA-receptor-mediated gamma
rhythms in the ACC of AppNL-G-F KI mice could be related to
reduced Grin2b or presynaptic release through Munc18-1.
Fig. 5. Gamma oscillations in the
amygdala and anterior cingulate cortex
(ACC). (Ai) Pooled power spectrum of
gamma oscillatory activity in the
basolateral amygdala in wild-type (WT;
black) and AppNL-G-F KI (blue) mice. (Aii)
Example traces showing 500 ms of gamma
oscillatory activity in WT (black) and
AppNL-G-FKI (blue) mice. Scale bar: 50 mV.
(Aiii) Graph showing the effect of NMDA
receptor antagonism (20 mM CPP) on the
frequency of basolateral amygdala gamma
oscillations (see key at bottom of figure).
(Aiv) Graph showing the effect of NMDA
receptor antagonism (20 mM CPP) on the
amplitude of basolateral amygdala gamma
oscillations. (Bi) Pooled power spectrum of
gamma oscillatory activity in the ACC inWT
(black) and AppNL-G-F KI (blue) mice. (Bii)
Example traces showing 500 ms of gamma
oscillatory activity in WT (black) and
AppNL-G-FKI (blue) mice. Scale bar: 20 mV.
(Biii) Graph showing the effect of NMDA
receptor antagonism (20 mM CPP) on the
frequency of ACC gamma oscillations.
(Biv) Graph showing the effect of NMDA
receptor antagonism (20 mM CPP) on the
amplitude of ACC gamma oscillations. Key:
dark colours represent control recordings,
light colours represent recordings with
CPP. All statistics used t-tests. *P<0.05.
Error bars are s.e.m. Wild-type n=5,
AppNL-G-F KI n=5.
Fig. 6. Gene expressionwithin the frontal
cortex and amygdala. (A) Although
AppNL-G-F KI mice (black bars) generally
had higher expression of our selected
genes within the amygdala, these were not
significantly different to wild-type mice
(white bars). (B) Within the frontal cortex,
expression of both Grin2b and Stxbp1
(Munc18-1) were significantly reduced in
AppNL-G-F KI mice. All statistics used t-tests.
*P<0.05. Error bars are s.e.m. Wild-type
n=6, AppNL-G-F KI n=6.
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DISCUSSION
Within the current study, we have further characterised the
behavioural profile of a new generation of App KI mice. When
tested at 8 months, AppNL-G-F KI mice show changes in behaviour
relative to controls. AppNL-G-F KI mice exhibited deficits in social
olfactory discrimination, but not in sociability. In anxiety-assessing
tasks,AppNL-G-FKImice exhibited task-dependent changes: (1) in the
OF, they showed increased thigmotaxis and reduced centre time, i.e.
an ostensibly anxiogenic profile; (2) in the EPM, they showed
reduced closed-arm, and increased open-arm, time, i.e. an ostensibly
anxiolytic profile. We discuss this seemingly contradictory profile
further below. Briefly, one view is that these anxiety-related changes
in AppNL-G-F KI mice, being contradictory, likely do not reflect a
simple shift towards one or other extreme of emotionality. Rather,
their combined ostensibly anxiogenic OF, yet ostensibly anxiolytic
EPM, profile could hint at altered mechanisms affecting decision
making (e.g. ‘disinhibition’ in the EPM). If so, this ideawould predict
mild/absent amygdalar changes combined with marked prefrontal
cortical changes. Consistent with this idea, alterations in
microstructure, glutamatergic-dependent gamma oscillations, and
glutamatergic gene expression were all observed in the prefrontal
cortex, but not the amygdala, of AppNL-G-F KI mice. Specifically, in
AppNL-G-F mice: DTI detected increases in MD, RD and AxD in the
OFC and ACC; slice recordings showed that ACC prefrontal gamma
mechanisms were unusual in being NMDA-receptor independent;
and, finally, likely relatedly, quantitative real-time PCR (qPCR)
showed reduced expression of Grin2b (encoding the 2B subunit of
the NMDA receptor) in the prefrontal cortex. We speculate that the
NMDA-receptor-independent ACC gamma oscillations could reflect
compensatory changes following reduced NMDA receptor
expression.
Within the current study, we observed a conflicting phenotype
between increased thigmotaxis in the OF (anxiogenic) and increased
time in the open arms in the EPM (anxiolytic). Others have examined
the anxiety profile in AppNL-G-F KI mice using the OF and found that
6-month-old mice spent more time in the OF centre zone (Latif-
Hernandez et al., 2017). However, others have found no difference in
time spent in the centre of an OF for 6-month-old AppNL-G-FKI mice
(Whyte et al., 2018). Latif-Hernandez et al. (2017) and Whyte et al.
(2018) did not specifically quantify thigmotaxis in the OF, limiting
comparisons to our study. Interestingly, locomotion within the OF
appears to vary by age. Distance travelled in the OF is significantly
greater in 6-month-old AppNL-G-FKI mice, whereas, at 8 months (the
current study) and 10 months of age, there were no significant
differences (Latif-Hernandez et al., 2017; Whyte et al., 2018),
suggesting hyperactivity is only detectable in younger mice.
Like our study, Latif-Hernandez et al. (2017) also used the EPM
to explore anxiety behaviours in AppNL-G-F KI mice. However,
unlike us, they compared the behaviour of AppNL-G-FKI mice to that
of AppNL KI mice only, and not to control wild-type mice. They
found that AppNL-G-F KI mice spent more time in the open arms at
6 months of age (Latif-Hernandez et al., 2017), which we replicated
at 8 months of age. A very recent study has also found that 6- to 9-
month-old AppNL-G-F KI mice spent more time in the EPM open
arms (Sakakibara et al., 2018). Together with our study, then, three
independent studies suggest that AppNL-G-F KI mice display an
anxiolytic profile in the EPM. The ostensible contradiction between
our results for the AppNL-G-FKI mice in the OF (higher thigmotaxis)
and EPM (lower centre time, higher open-arm time) is curious but
not unique. Tg2576 mice, an AD model overexpressing mutant
APP with the Swedish KM670/671NL mutation, also show OF
thigmotaxis yet increased time in the EPM open arms (Lalonde
et al., 2003). It is possible that the increased time spent in the open
arms reflects a disinhibition phenotype. Disinhibition is a well-
established, albeit less common, AD phenotype (Chung and
Cummings, 2000; Hart et al., 2003), which could be manifested
within the current study as a failure to inhibit the choice to enter the
open arm. Given the lack of specific data to speak to a disinhibition
hypothesis, it is clear that future anxiety testing in AppNL-G-F KI
mice will require multiple paradigms to clearly delineate anxiety
from disinhibition.
Could perseveration help to explain the seemingly contradictory
profiles we observed in AppNL-G-F KI mice, i.e. the ostensibly
anxiogenic profile in the OF and the ostensibly anxiolytic profile in
the EPM? Prefrontal cortex damage can lead to perseverative
behaviour, and we show prefrontal cortex alterations in AppNL-G-F
KI mice. Several studies find that dopamine transporter knock-out
(DAT-KO) mice, which have aberrant prefrontal connectivity (Zhang
et al., 2010), exhibit perseverative and stereotyped behaviour (e.g.
Fox et al., 2013; Pogorelov et al., 2005; Ralph et al., 2001).
Perseverative behaviour sometimes co-occurs (Pogorelov et al.,
2005), and sometimes does not co-occur (Fox et al., 2013; Powell
et al., 2004), with thigmotaxis in the same OF test in these mice.
However, such perseverative behaviour reliably co-occurs with
hyperactivity and stereotyped movements; in contrast, we did not
observe any such hyperactivity, and could see no sign whatsoever of
any unusual patterns of locomotion in AppNL-G-FKI mice. Moreover,
most importantly, in a study that explicitly investigated anxiety-
related profiles in DAT-KO mice (Pogorelov et al., 2005), the
perseverative behaviour co-occurred with an anxiogenic profile in
both the OF (more thigmotaxis) and the zeromaze (reduced open-arm
time), an equivalent of the EPM. Furthermore, diazepam normalised
the DAT-KO versus wild-type differences in in the zero maze, which
the authors interpreted as suggesting that there is a genuine anxiety-
like characteristic in the DAT-KO mice (Pogorelov et al., 2005).
Another mouse model incorporating prefrontal alterations and
perseverative behaviour is the MAO-ANeo mouse (Bortolato et al.,
2011). This mouse showed somewhat higher thigmotaxis in the OF,
but open-arm entries/time were perfectly normal in the EPM. In
summary, then, the relationship between perseverative behaviour and
anxiety measures is not straightforward, and there is no particular
evidence to suggest that perseveration resolves the apparent
‘OF-anxiogenic versus EPM-anxiolytic’ discrepancy raised by our
findings. To our knowledge, only amyloid-related ADmouse models
show this contradictory profile.
Several other AD mouse models exhibit impairments in social
behaviour, including APPswe/PS1 (Filali et al., 2011) and Tg2576
(Deacon et al., 2009) mice. Latif-Hernandez et al. (2017) examined
social behaviours in AppNL-G-FKI mice and found that, although not
significant, the discrimination ratio for exploring a novel mouse
compared to an empty cage, and for comparing between the
previously explored mouse and a second novel mouse, had fallen to
chance by 10 months of age. We found that AppNL-G-F KI mice
show robust preference for exploring a novel conspecific compared
to an empty cage. We did, however, find that social preference, as
measured by discriminating a social odour cue, was impaired in
female AppNL-G-F KI mice. A key difference between our study and
Latif-Hernandez et al. (2017) is that they used only female mice.
Our study, with mixed-sex groups, suggests that females show a
greater impairment in social behaviour than males, which will be an
important consideration for future studies. Generally, the use of
single-sex groups has been a problem for other AD mouse model
literature. To the best of our knowledge, only two studies have used
mixed-sex groups to investigate social deficits. In both cases, aged
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3xTg-AD mice (>12 months old) have shown female-specific
differences in social engagement (Bories et al., 2012; Torres-Lista
and Gimenez-Llort, 2019). Although our findings are corroborative
with these studies, more work is required to understand the nature of
socially relevant sex differences in AD.
The ACC and amygdala are brain regions that have been well
established with mediating anxiety/fear and social behaviours
(Davidson, 2002; Davis, 1992; Davis et al., 1994; Etkin et al., 2011).
Additionally, the prefrontal cortex has a well-established link to
behavioural decision making, especially for affective stimuli (Dias
et al., 1996). This may relate to our proposed ‘disinhibition’
explanation for the dichotomy in our two anxiety tasks, highlighting
the prefrontal cortex as the critical brain region in AppNL-G-F KI mice.
Furthermore, these areas are also susceptible to degeneration in early
ADpathology (Huanget al., 2002;Poulin et al., 2011;Scheff andPrice,
2001).With these findings inmind,we hypothesised that structural and
functional alterationswithin the amygdala andmedial prefrontal cortex
could partly explain behavioural impairments. As it turned out, we
found little evidence for neurodegeneration-linked changes in the
amygdala, but did find such changes in the prefrontal cortex.
Our analysis of microstructural integrity using DTI revealed that
the prefrontal cortex of AppNL-G-F KI mice, including the OFC and
ACC, was substantially altered, and the functional consequences of
these changes to the ACC was that gamma oscillations lost their
dependency upon NMDA receptors, notably GluN2B receptors.
Thus far, there have been limited investigations into the biological
pathways altered in AppNL-G-F KI mice. Using rsfMRI, Latif-
Hernandez et al. (2017) found that the cingulate cortex was the
most significantly altered brain region, with no visible impairment in
the amygdala. Although further work is required to definitively
describe the physiological pathways that explain the altered behaviour
in AppNL-G-F KI mice, our findings present an important step in this
process. Although other brain regions likely contribute to changes in
anxiety and social behaviours [gamma oscillations have also been
found altered in the medial entorhinal cortex of AppNL-G-F KI mice
(Nakazono et al., 2017)], the prefrontal cortex could represent a key
region. Neural oscillations in the medial prefrontal cortex have clear
links to anxiety behaviours, both in the OF and EPM (Adhikari et al.,
2010), and medial prefrontal cortex gamma is required for the
expression of social novelty (Cao et al., 2018). Additionally, the loss
of GluN2B or its phosphorylation impairs social behaviour (Jacobs
et al., 2015; Wang et al., 2011) and increases anxiety in the OF
(Hanson et al., 2014) and the EPM (Delawary et al., 2010).
Furthermore, NMDA receptors are necessary for gamma oscillations
mediated by the goblet cell interneurons within the entorhinal cortex
(Middleton et al., 2008), with specific antagonism of GluN2B
significantly reducing hippocampal gamma power (Hanson et al.,
2013). Together, insoluble Aβ overexpression in AppNL-G-F KI mice
results in prefrontal cortical alterations, and this may be in part be
through gamma oscillatory impairments by reduced GluN2B
expression. This indicates that social and anxiety behavioural
impairments in AppNL-G-F KI mice may be driven by regions that
do not include the amygdala, although further work will be required
to corroborate this, including the specific antagonism of GluN2B
using slice electrophysiology.
An important limitation of the current study is that we have not
examined anatomical or neurobiological mechanisms by sex. Female
AppNL-G-F KI mice showed weaker performance in social olfactory
discrimination, suggestive of sex differences. Future studies should
consider the contribution of sex differences to both anatomical and
physiological outputs in AppNL-G-F KI mice. Additionally, our
behavioural and neurobiological data varies at the time point in which
the experiments took place (∼8 months for behaviour, ∼9 months for
DTI and ∼12 months for electrophysiology). Thus, we cannot rule
out a worsening/degenerating phenotype partly explaining the
electrophysiological data.
A second limitation is that we have not performed physiological
(i.e. electrophysiological and molecular) analysis on the
hippocampus. Although DTI found alterations in the hippocampal
microstructure of AppNL-G-FKI mice, our aim herein was to examine
brain regions more closely associated with anxiety and social
behaviours, for which the hippocampus has some, but conflicting,
evidence. Thus far, limited electrophysiological studies of the
hippocampus have taken place inAppNL-G-FKImice, although long-
term potentiation has been found reduced (Moriguchi et al., 2018).
Thus, moving forwards, it will be important to examine the
hippocampus in addition to prefrontal regions to ascertain how
various brain regions contribute to the altered behaviours.
The findings presented herein show a clear dichotomy of anxiety
behaviours between two different paradigms (anxiolytic-like in the
EPM versus anxiogenic-like in the OF). We have argued that this
pattern may be linked to degeneration in neural regions related to
decision making, notably the medial prefrontal cortex, rather than to
emotionality per se. We further postulate that microstructural
integrity, gamma oscillatory function and Grin2b expression within
the prefrontal cortex may, in part, explain these behavioural
changes. Our data continues to highlight the importance of using
AD models that do not have the limitation of APP overexpression.
Further studies will be required to continue to refine the mechanisms
that explain anxiety impairments in AppNL-G-F KI mice.
MATERIALS AND METHODS
Ethics
All procedures were approved by the Durham University and University of
York Animal Ethical and Welfare Review Boards, and were performed
under UK Home Office Project and Personal Licenses in accordance with
the Animals (Scientific Procedures) Act 1986.
Experimental animals
Mice
Full details of the animals can be found elsewhere (Saito et al., 2014). Upon
arrival at Durham, mice were backcrossed once to the C57BL/6J line, which
was the same background strain as the previous institution where they were
bred. Homozygote AppNL-G-F KI and wild-type littermate mice were bred in
house by heterozygote pairings and were weaned at P21 and ear biopsied for
genotyping. Mice were housed with between two and five littermates, with a
12:12 light/dark cycle commencing at 07:00. Enrichment was provided with
Perspex domes and shreddable nesting material. Genotyping protocols can be
found elsewhere (Saito et al., 2014). In brief, the following primers were used
(5′-3′): WT: TGTAGATGAGAACTTAAC, E16WT: ATCTCGGAAGTG-
AAGATG, loxP: CGTATAATGTATGCTATACGAAG and E16Mut: AT-
CTCGGAAGTGAATCTA. PCR was run at 53°C for 30 cycles for 30 s.
Experimental design
Behaviour
In total, 21 wild-type [nine male (8.19±0.12 months; mean±s.e.m.), 11
female (8.10±0.04 months)] and 19 AppNL-G-F homozygotes [ten male
(7.93±0.17 months), nine female (7.44±0.43 months)] were used in
behavioural testing by random allocation. Mice were transferred to the
testing room and allowed at least 30 min habituation prior to testing. All
mice were transferred to the apparatus via cardboard tubes. Experiments
took place in the light phase between 09:00 and 17:00. All apparatus was
cleaned with alcohol wipes between subjects. A minimum of 2 days was
provided between experiments.
Testing procedures can be found elsewhere (Dachtler et al., 2014). All trials
were recorded by Any-maze (Stoelting, Dublin, Ireland) tracking software.
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Mice undertook the following tests in this order: OF, EPM, social approach,
social recognition and social olfactory discrimination. In brief, mice were
placed into a 44 cm2 white Perspex arena and allowed free ambulation for
30 min. The floor of the arenawas divided byAny-maze into an outer zone of
8 cm and a centre zone of 17.5 cm2 (note: we have not reported on the
intermediate zone). Time spent and entries into these zones, along with
distance travelled, were measured. The EPM, social approach, social
recognition and social olfaction discrimination were run as in Dachtler et al.
(2014), except that novel conspecifics and soiled bedding was sex matched
with adult mice to the test subject. For the social tests, following a 15 min
habituation, the test mouse was allowed 10 min of free exploration. The inter-
trial interval between social novelty and social recognition experiments was
5 min. At the conclusion of testing, mice were used for electrophysiology,
killed by perfusion fixation with 4% paraformaldehyde in phosphate buffered
saline (PBS) or killed by cervical dislocation for molecular biology.
Diffusion tensor MRI
Eight wild-type [four male (9.02±0.63 months), four female (9.43±
0.30 months)] and eight AppNL-G-F homozygotes [four male (8.88±
0.22 months), four female (9.89±0.21 months)] were used in MRI. Image
acquisition has been described elsewhere (Pervolaraki et al., 2017, 2019).
MRI was performed on a vertical 9.4 Tesla spectrometer (Bruker AVANCE II
NMR, Ettlingen, Germany). During imaging, the samples were placed in
custom-built MR-compatible tubes containing Fomblin Y (Sigma-Aldrich,
Poole, Dorset, UK). The following acquisition protocol was used: TE: 35 ms,
TR: 700 ms, 1 signal average. The field of view was set at 168×128×96 mm,
with a cubic resolution of 62.5 μm/pixel and a B value of 1625 s/mmwith 30
directions.
The ex vivo mouse brain 3D diffusion-weighted images were reconstructed
from the Bruker binary file using DSI Studio (http://dsi-studio.labsolver.org).
Directionally encoded colour map (DEC) images were generated by
combining the information from the primary eigenvectors, diffusion images
and the FA. Regions were extracted by manually segmenting OFC, ACC,
hippocampal and whole-amygdalar regions using a mouse brain atlas
(Franklin and Paxinos, 2008). We chose to focus on the aforementioned
brain regions as these have been linked to social behaviour (Pervolaraki et al.,
2019). Additionally, the hippocampus (Bannerman et al., 2004; McHugh
et al., 2004), amygdala (Davis, 1992; Davis et al., 1994) and prefrontal cortical
regions (including theACC) (Davidson, 2002; Etkin et al., 2011) have all been
linked to anxiety. Extraction of FA, MD, AxD and RD was performed within
selected segmented brain regions, with three 100 µm sections (one anterior and
one posterior to the segmented section) extracted. A full atlas-based
description of the segmentation can be found in Pervolaraki et al. (2019).
Electrophysiology
Anterior cingulate or basolateral amygdala coronal slices (450 µm thick) were
prepared from age-matched, 12-month-old male wild-type (n=5) mice and
AppNL-G-FKI (n=5) mice. Animals were anaesthetised with inhaled isoflurane,
immediately followed by an intramuscular injection of ketamine (100 mg/kg
body weight) and xylazine (10 mg/kg body weight). Animals were perfused
intracardially with 50-100 ml of modified artificial cerebrospinal fluid
(ACSF), which was composed of the following (in mM): 252 sucrose, 3
KCl, 1.25 NaH2PO4, 24 NaHCO3, 2 MgSO4, 2 CaCl2 and 10 glucose. The
brain was removed and submerged in cold (4-5°C) ACSF during dissection.
Once dissected, slices were maintained at 32°C in a standard interface
recording chamber containing oxygenated ACSF consisting of (in mM): 126
NaCl, 3 KCl, 1.25 NaH2PO4, 1 MgSO4, 1.2 CaCl2, 24 NaHCO3 and 10
glucose. Persistent, spontaneous gamma oscillations were generated through
the bath application of 400 nM kainic acid (KA). Further perfusion, through
bath application of 20 mM 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic
acid (CPP), was conducted to antagonise NMDA receptors. All salts were
obtained from BDH Chemicals (Poole, UK) or Sigma-Aldrich (Poole, UK),
and KA and CPP were obtained from BioTechne (MN, USA).
Extracellular field recordings were obtained using borosilicate
micropipettes (Harvard Apparatus) filled with ACSF and had resistances
of 2-5 MΩ. Recordings were bandpass filtered at 0.1-300 Hz. Power spectra
were derived from Fourier transform analysis of 60 s epochs of data, and
results were presented as mean±s.e.m.
RNA extraction and qPCR
For molecular biology, mice underwent cervical dislocation, with the brain
extracted and placed into a mouse brain blocker (David Kopf Instruments,
Tujunga, CA, USA). The olfactory bulbs were removed, followed by a
section of tissue from bregma 3.56 to 2.58 mm, and from bregma −0.82 to
−2.80 mm. The prefrontal cortex tissue was snap frozen. The posterior
section was then further dissected with a scalpel to remove the amygdalar
region, which was then snap frozen and stored at −80°C until use. Six wild-
type [four male, two female (10.26±0.41 months)] and six AppNL-G-F
homozygotes [three male, three female (9.49±0.13 months)] were used for
qPCR. Brain tissue of extracted regions (amygdala and prefrontal cortex)
were homogenised by TissueRuptor drill (Qiagen, Manchester, UK), with
∼90 mg used for RNA extraction. Instructions were followed as per the Bio-
Rad Aurum Total RNA Fatty and Fibrous Tissue Kit (Bio-Rad, Hemel
Hempstead, UK, cat. # 7326830) and our previously optimised protocol
(Pervolaraki et al., 2018). RNA quantity and quality were confirmed by
Nanodrop spectrophotometer. cDNA was generated by the iScript cDNA
Synthesis Kit (Bio-Rad, UK), with 1 µg of RNA used per reaction.
Primers (Table 1) were designed using Primer3 after identifying the gene
sequence on NCBI (https://www.ncbi.nlm.nih.gov/). Primers (Integrated
DNA Technologies, Leuven, Belgium) were tested for specificity and run
conditions optimised by PCR using whole-brain cDNA. Plates were run
with 10 µl per reaction, with 1 µl of cDNA, Bio-Rad SYBR Green (cat. #
1725121) and 300 nM primers. Samples were run in triplicate using the
protocol of 95°C for 3 min, followed by 95°C for 10 s, 60°C for 30 s
repeated 35 times. Gene expression was imaged using a Bio-Rad CFX
Connect and analysed using Bio-Rad Connect Manager, and quantified
using the 2ΔΔCt method against the housekeeping gene Gapdh, which did
not differ between the genotypes.
Immunostaining
The protocol for staining for amyloid plaques can be found elsewhere (Ly
et al., 2011). Tissue from one wild-type and one AppNL-G-F KI mouse
previously scanned by MRI was washed and immersed in 30% sucrose for
>48 h. Tissue was cryosectioned at 30 µm, followed by immersion in 88%
formic acid for 15 min. Endogenous peroxidase activity was quenched with
H2O2 for 30 min, followed by blocking in 2% bovine serum albumin (BSA)
(Thermo Fisher Scientific) for 1 h at room temperature. Sections were then
incubated with 1:500 6E10 (BioLegend, San Diego, CA, USA; cat. #
803001, lot # B225309) overnight at 4°C, followed by 1:500 biotinylated
anti-mouse (Vector Labs, Peterborough, UK) for 2 h at room temperature.
Sections were then reacted with Vectastain ABC kit (Vector Labs) followed
by diaminobenzidine (DAB) treatment (Vector Labs) prior to mounting on
slides for imaging by light microscopy.
Data availability
Datasets will be made available subject to responsible request to J.D.
Data analysis
All data are expressed as mean±s.e.m. Group sizes were calculated assuming
an η2 of 0.14 for a predicted power of 0.8 with α=0.05. To assess the variance
between genotypeswithin a single brain structure across hemispheres, datawas
analysed by within-subject repeated-measures two-way ANOVAs or unpaired
Table 1. Primer design for qPCR
Gene Orientation Sequence (5′-3′)
Grin1 Forward CCTACTCCCAACGACCACTT
Reverse AGACGCGCATCATCTCAAAC
Grin2a Forward TTGGGAGCGGGTACATCTTT
Reverse CTCCTGCCATGTTGTCGATG
Grin2b Forward GGAGAGGGTGGGAAAATGGA
Reverse CACTGAGAGGGTCCACACTT
Dlg4 Forward TCAACAGTGTGGGGCTAGAG
Reverse TGCCCAAGTAGCTGCTATGA
Gapdh Forward CAACTCCCACTCTTCCACCT
Reverse GAGTTGGGATAGGGCCTCTC
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t-tests. To correct for multiple comparisons, we employed the Benjamini-
Hochberg procedure, with false discovery rate set to 0.4 (corrected P-values
stated). Behaviour was analysed with ANOVAs, followed by tests of simple
main effects. Non-significant statistical results, particularly hemisphere
comparisons, can be found in the supplementary information. Statistical
testing and graphs were made using GraphPad Prism version 6 and SPSS v22.
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Brain Region DTI Measure ANOVA 
Comparison 
F Value P Value 
Anterior 
Amygdala 
FA Genotype F(1, 14) <1 P = 0.384 
  Hemisphere F(1, 14) = 2.76 P = 0.095 
Posterior 
Amygdala 
FA Genotype F(1, 14) <1 P = 0.300 
  Hemisphere F(1, 14) <1 P = 0.184 
BLA FA Genotype F(1, 14) <1 P = 0.268 
  Hemisphere F(1, 14) <1 P = 0.168 
Anterior 
Amygdala 
MD Genotype F(1, 14) <1 P = 0.179 
  Hemisphere F(1, 14) <1 P = 0.353 
Posterior 
Amygdala 
MD Genotype F(1, 14) <1 P = 0.274 
  Hemisphere F(1, 14) <1 P = 0.226 
BLA MD Genotype F(1, 14) = 3.23 P = 0.084 
  Hemisphere F(1, 14) = 1.55 P = 0.137 
Anterior 
Amygdala 
AD Genotype F(1, 14) <1 P = 0.173 
  Hemisphere F(1, 14) <1 P = 0.242 
Posterior 
Amygdala 
AD Genotype F(1, 14) <1 P = 0.221 
  Hemisphere F(1, 14) <1 P = 0.252 
BLA AD Genotype F(1, 14) = 5.81 P = 0.053 
  Hemisphere F(1, 14) = 2.55 P = 0.105 
Anterior 
Amygdala 
RD Genotype F(1, 14) <1 P = 0.189 
  Hemisphere F(1, 14) <1 P = 0.247 
Posterior 
Amygdala 
RD Genotype F(1, 14) <1 P = 0.332 
  Hemisphere F(1, 14) <1 P = 0.194 
BLA  RD Genotype F(1, 14) = 2.67 P = 0.100 
  Hemisphere F(1, 14) <1 P = 0.205 
 
 
Table S1 Statistical analysis of the anterior (Bregma -1.94 mm) and posterior (Bregma 
-3.28 mm) amygdala, analysed for fractional anisotropy (FA), mean diffusion (MD), 
axial diffusion (AD) and radial diffusion (RD). Corrected P values stated (Benjamini-
Hochberg corrected). 
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Brain Region DTI Measure ANOVA 
Comparison 
F Value P Value 
Anterior 
Hippocampus 
FA Genotype F(1,14) <1 P = 0.342 
  Hemisphere F(1, 14) = 2.18 P = 0.116 
Posterior 
Hippocampus 
FA Genotype F(1, 14) <1 P = 0.263 
  Hemisphere F(1, 14) <1 P = 0.305 
Anterior 
Hippocampus 
MD Genotype F(1, 14) = 2.89 P = 0.089 
  Hemisphere F(1, 14) <1 P = 0.311 
Posterior 
Hippocampus 
MD Genotype F(1, 14) = 12.18 P = 0.011 
  Hemisphere F(1, 14) = 1.07 P = 0.163 
Anterior 
Hippocampus 
AD Genotype F(1, 14) = 7.56 P = 0.047 
  Hemisphere F(1, 14) <1 P = 0.316 
Posterior 
Hippocampus 
AD Genotype F(1, 14) = 4.45 P = 0.068 
  Hemisphere F(1, 14) <1 P = 0.211 
Anterior 
Hippocampus 
RD Genotype F(1, 14) = 1.52 P = 0.142 
  Hemisphere F(1, 14) <1 P = 0.237 
Posterior 
Hippocampus 
RD Genotype F(1, 14) <1 P = 0.005 
  Hemisphere F(1, 14) <1 P = 0.158 
 
 
Table S2 Statistical analysis of the anterior (Bregma -1.94 mm) and posterior (Bregma 
-3.28 mm) hippocampus for fractional anisotropy (FA), mean diffusion (MD), axial 
diffusion (AD) and radial diffusion (RD). Corrected P values stated (Benjamini-
Hochberg corrected).  
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Figure S1. A. No significant differences were observed for entries made to the outer 
zone (genotype F(1, 35) = 1.43, p = 0.240, genotype x sex F(1, 35) <1, p = 0.928). B. AppNL-
G-F KI mice made fewer entries into the centre zone (genotype F(1, 35) = 5.12, p = 0.030, 
genotype x sex F(1, 35) <1, p = 0.727). C. AppNL-G-F KI mice spent significantly less time 
in the centre zone in the elevated plus maze (genotype F(1, 35) = 5.39, p = 0.030, 
genotype x sex F(1, 35) <1, p = 0.850). D. There was a main effect of genotype for the 
number of head dips made in the elevated plus maze (genotype F(1, 35) = 5.13, p = 
0.030, genotype x sex F(1, 35) <1, p = 0.577). E. Distance travelled in the elevated plus 
maze was similar between the genotypes (genotype F(1, 35) <1, p = 0.861, genotype x 
sex F(1, 35) <1, p = 0. 400). 
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Figure S2. Fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD) and 
radial diffusivity (RD) in the amygdala. The entire amygdala was segmented from DTI 
images at two regions; anterior (A, C, E, G: Bregma -1.94 mm) and posterior (B, D, F, 
H: Bregma -2.46 mm). No significant differences were observed between the 
genotypes for anterior or posterior regions. Error bars represent s.e.m. Wild-type n=8, 
AppNL-G-F KI n=8. 
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Figure S3. Amyloid plaque staining in wild-type and AppNL-G-F KI mice in the 
orbitofrontal cortex (OFC), the anterior cingulate cortex (ACC) the amygdala, and the 
anterior and posterior hippocampus. Dashed line represents the brain regions of 
interest.  
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